Great Point Partners’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-579,667
| Closed | -$1.67M | – | 48 |
|
2023
Q3 | $1.67M | Sell |
579,667
-1,688,390
| -74% | -$4.86M | 0.3% | 38 |
|
2023
Q2 | $8.64M | Sell |
2,268,057
-885,149
| -28% | -$3.37M | 1.69% | 23 |
|
2023
Q1 | $5.86M | Buy |
3,153,206
+1,190,807
| +61% | +$2.21M | 1.15% | 27 |
|
2022
Q4 | $4.51M | Buy |
1,962,399
+1,513,350
| +337% | +$3.48M | 0.88% | 35 |
|
2022
Q3 | $1.45M | Buy |
+449,049
| New | +$1.45M | 0.35% | 35 |
|